Studying the Effects of Phentermine on Eating Behavior
Status: | Completed |
---|---|
Conditions: | Obesity Weight Loss |
Therapuetic Areas: | Endocrinology |
Healthy: | No |
Age Range: | 18 - 60 |
Updated: | 4/2/2016 |
Start Date: | July 2012 |
End Date: | June 2014 |
Contact: | Simona Kaplan, BA |
Email: | edru@nyspi.columbia.edu |
Phone: | 212-543-5739 |
The Quantification of Ingestive Behavior
The goal of this study is to determine whether one week of phentermine compared to placebo
administration results in changes in food intake during a laboratory meal.
administration results in changes in food intake during a laboratory meal.
This study aims to explore whether short-term measures of eating behavior can be related to
later, longer-term weight loss. In a double-blind, randomized fashion, participants will be
asked to take study medication for three weeks: one week of phentermine and two weeks of
placebo. At the end of the first and third weeks, participants will be asked to participate
in a range of eating behavior studies. Following this three-week, double-blind phase,
participants will be offered 6 months of open treatment for weight loss.
later, longer-term weight loss. In a double-blind, randomized fashion, participants will be
asked to take study medication for three weeks: one week of phentermine and two weeks of
placebo. At the end of the first and third weeks, participants will be asked to participate
in a range of eating behavior studies. Following this three-week, double-blind phase,
participants will be offered 6 months of open treatment for weight loss.
Inclusion Criteria:
- BMI between 30-40kg/m2
- Stable weight (+5 lbs) for a minimum of 3 months
- Systolic Blood Pressure <140mm Hg
- Diastolic Blood Pressure <90 mm Hg
- Pulse <95 beats per minute
- English language proficiency
Exclusion Criteria:
- Previous unsuccessful trial of phentermine
- Prior adverse reaction to phentermine
- On any antidepressant medications,especially monoamine oxidase inhibitors(MAOI)
- History of neurological disorder (e.g. dementia)
- History of moderate or severe head injury
- Current or past history of coronary artery disease
- Current or past history of stroke or transient ischemic attack
- Current or past history of heart arrhythmias
- Current of past history of congestive heart failure
- Current or past history of peripheral artery disease
- Current or past history of liver disease
- Current or past history of kidney disease
- Uncontrolled diabetes mellitus (type I or II)
- Narrow-angle glaucoma
- Hypo- or hyper-thyroidism not adequately treated
- On medications (prescribed or OTC) known to affect appetite (e.g. diet pills),
weight, or metabolism
- Current or past history (within the past 12 months) of major depression
- Current or past history (past 12 months) of alcohol or drug abuse or dependence
- Current or past history (lifetime) of amphetamine abuse or dependence
- Known history of learning disorder or developmental disability
- Current or past Attention Deficit Hyperactivity Disorder (ADHD)
- Pregnancy, planning to become pregnant, or lactation within the previous 6 months
- Waist circumference greater than 188cm
- Indwelling metallic object (e.g., pacemaker,pump), non-removable metal jewelry,
medicinal patch or recent metallic ink tattoo
- Significant claustrophobia
- Current or past history of anorexia nervosa,bulimia nervosa (within the past 12
months) or binge eating disorder (within the previous 6 months)
We found this trial at
1
site
New York, New York 10032
Click here to add this to my saved trials